Durvalumab治疗放化疗后Ⅲ期非小细胞肺癌患者的总生存期获益
评价者:蒋苏静
1
, 谢聪颖
1
, 文献合成者:卢红莲
2
Overall Survival with Durvalumab after Chemoradio-therapy in Stage Ⅲ NSCLC
Reviewers: JIANG Su-jing
1
, XIE Cong-ying
1
, Literature Co-worker: LU Hong-lian
2
